东北制药: 关于控股股东部分股份质押的公告

Core Viewpoint - The company, Northeast Pharmaceutical Group Co., Ltd., has received notification from its controlling shareholder, Liaoning Fangda Group Industrial Co., Ltd., regarding the pledge of a portion of its shares [2]. Summary by Relevant Sections Share Pledge Details - Liaoning Fangda Group pledged 48,740,000 shares, which accounts for 14.81% of its total holdings and 3.42% of the company's total share capital [2]. - The pledge is not part of a controlling shareholder's actions and does not affect the company's overall shareholding structure [2]. Cumulative Pledge Situation - Before this pledge, the total number of shares pledged by Liaoning Fangda Group was 329,068,713, representing 23.06% of its holdings [5]. - After the current pledge, the total pledged shares will increase to 285,062,211, which is 42.42% of the total shares held by the group [5]. - The company will continue to monitor the share pledge situation and will disclose relevant information in accordance with regulations [5].